These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23235401)

  • 21. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.
    Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5022-8. PubMed ID: 17003086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities.
    Miranda M; Ceperuelo-Mallafré V; Lecube A; Hernandez C; Chacon MR; Fort JM; Gallart L; Baena-Fustegueras JA; Simó R; Vendrell J
    Metabolism; 2009 Dec; 58(12):1762-8. PubMed ID: 19615702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome].
    Chu YL; Sun YY; Qiu HY; Li HF
    Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):176-9. PubMed ID: 15130378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
    Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
    Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different expression and localization of aquaporin 7 and aquaporin 9 in granulosa cells, oocytes, and embryos of patients with polycystic ovary syndrome and the negatively correlated relationship with insulin regulation.
    Song WY; Wang Y; Hou XM; Tian CC; Wu L; Ma XS; Jin HX; Yao GD; Sun YP
    Fertil Steril; 2021 Feb; 115(2):463-473. PubMed ID: 33579525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The plasma level and gene expression of resistin in polycystic ovary syndrome.
    Zhang J; Zhou L; Tang L; Xu L
    Gynecol Endocrinol; 2011 Dec; 27(12):982-7. PubMed ID: 21557697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS.
    Dolfing JG; Stassen CM; van Haard PM; Wolffenbuttel BH; Schweitzer DH
    Hum Reprod; 2011 Jun; 26(6):1495-500. PubMed ID: 21406446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphoprotein enriched in diabetes gene product (Ped/pea-15) is increased in omental adipose tissue of women with the polycystic ovary syndrome: ex vivo regulation of ped/pea-15 by glucose, insulin and metformin.
    Tan BK; Chen J; Adya R; Randeva HS
    Diabetes Obes Metab; 2011 Feb; 13(2):181-4. PubMed ID: 21199270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
    Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
    Takeuchi T; Tsutsumi O; Taketani Y
    Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
    Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.
    Tan BK; Chen J; Lehnert H; Kennedy R; Randeva HS
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2764-72. PubMed ID: 17456573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Depot-specific expression of caveolin-1 in human adipose tissue and their relationship with obesity and insulin resistance].
    Li XF; Lu HY; Jiang W; Qiu YW; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(20):1388-91. PubMed ID: 22883195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.